Selective internal radiation therapy by yttrium-90 microspheres for hepatocellular carcinoma after renal transplantation

Clinical Transplantation

Volumn 15, Issue 4, 2001, Pages 284-288

  Szeto, Cheuk Chun ^a,b   Wong, Teresa Yuk Hwa ^a   Leung, Chi Bon ^b   Leung, Thomas Wai Tong ^b   Wang, Angela Yee Moon ^a   Lui, Siu Fai ^a   Li, Philip Kam Tao ^b  

^a Departments of Medicine and Therapeutics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatocellular carcinoma; Kidney transplant; Radiotherapy

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; MICROSPHERE; YTTRIUM 90;

ABDOMEN; ADULT; ANGIOGRAPHY; ARTICLE; CADAVER KIDNEY; CASE REPORT; CATHETER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FLUOROSCOPY; FOLLOW UP; HUMAN; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER HYPERTROPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL; SYMPTOM; TUMOR NECROSIS;

ADULT; BRACHYTHERAPY; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B SURFACE ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LIVER NEOPLASMS; MICROSPHERES; YTTRIUM RADIOISOTOPES;

EID: 0034898428     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.150411.x     Document Type: Article

References (25)

1. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: A phase I and II study
2. 90yttrium microspheres
3. Diagnostic pharmacoscintigraphy with technetium-99m macroaggregated albumin in the prediction of tumor to normal uptake ratio during therapy of inoperable hepatocellular carcinoma with yttrium-90 microspheres
4. Measurement of lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin
5. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumors
6. Cancers complicating organ transplantation
7. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection
8. Screening for hepatocellular carcinoma
9. Early detection of hepatocellular carcinoma in hepatitis-B-positive renal transplant recipients
10. Hepatocellular carcinoma in Hong Kong: Clinical study on 340 cases
11. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients
12. Subclinical hepatocellular carcinoma in Hong Kong Chinese
13. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation
14. Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression
15. Chemotherapy studies in primary liver cancer: A prospective randomized clinical trial
16. Et De Traitement Du Carcinome Hepatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
17. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: Need for controlled trials
18. Hepatocellular carcinoma: Pilot trial of treatment with Y-90 microspheres
19. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma
20. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer
21. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
22. Treatment of inoperable primary pancreatic and liver cancer by intraarterial administration of radioactive isotope (Y-90 radiating microspheres)
23. Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy
24. Hepatic malignancies: Improved treatment with intraarterial Y-90
25. Internal radiation therapy for patients with primary or metastatic hepatic cancer